Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
Novartis hopes for better luck with bispecifics via $150M upfront Dren Bio deal
Fierce Biotech
Wed, 07/24/24 - 11:09 pm
Novartis
Dren Bio
cancer
bispecifics
Pharma aims to deliver personalized cancer therapies more quickly
Reuters
Wed, 07/24/24 - 11:48 am
cancer
oncology
drug development
personalized medicine
Scorpion snaps up $150M in series C funds to widen clinical plans for cancer pipeline
Fierce Biotech
Tue, 07/16/24 - 12:09 pm
Scorpion Therapeutics
funding
cancer
oncology
German biotech CatalYm cashes in on early-stage cancer data with $150M series D
Fierce Biotech
Tue, 07/16/24 - 11:55 am
CatalYm
cancer
monoclonal antibodies
visugromab
funding
Could pharma’s blockbuster immunotherapies work in dogs?
Pharma Voice
Thu, 07/11/24 - 11:16 am
Vetigenics
animal health
cancer
immunotherapy
GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study
BioSpace
Mon, 07/8/24 - 11:49 am
GLP-1
Ozempic
Novo Nordisk
Eli Lilly
obesity
cancer
Merck opts in on Orion's hormone-dependent cancer candidates
Fierce Biotech
Mon, 07/1/24 - 09:51 pm
Merck
Orion
biobucks
cancer
Cancer victims lose bid to block proposed J&J talc bankruptcy
Reuters
Sun, 06/30/24 - 09:49 pm
JNJ
legal
bankruptcy
cancer
FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug
Reuters
Thu, 06/27/24 - 11:18 am
Merck
Daiichi Sankyo
cancer
FDA
patritumab deruxtecan
antibody-drug conjugate
AI Enables Individualized Cancer Vaccines
BioSpace
Mon, 06/17/24 - 11:03 am
artificial intelligence
oncology
cancer
vaccines
cancer vaccines
Pfizer expects 8 blockbuster cancer drugs to come from each of 4 focus areas: exec
Fierce Pharma
Thu, 06/13/24 - 11:14 pm
Pfizer
oncology
cancer
Secondary Cancer Risk Is Low After CAR-T Cell Treatment: Stanford Study
BioSpace
Thu, 06/13/24 - 11:21 am
cancer
CAR-T
A ‘widening gap’ in access to new cancer meds drives efforts from City of Hope and Bristol Myers
Pharma Voice
Thu, 06/6/24 - 11:36 am
Bristol Myers Squibb
cancer
oncology
City of Hope
access
Clinical-stage cancer biotech Actuate latest to eye summer IPO
Fierce Biotech
Tue, 05/28/24 - 10:53 am
Actuate Therapeutics
IPOs
cancer
oncology
AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies
Fierce Biotech
Thu, 05/23/24 - 10:47 am
AstraZeneca
Harbour BioMed
Nona Biosciences
cancer
oncology
FogPharma, Artbio join forces to design a different radiopharma drug
BioPharma Dive
Tue, 05/14/24 - 11:00 pm
FogPharma
Artbio
radiopharmaceuticals
cancer
Could Cancer Vaccines Be the Next Big Breakthrough in Immunotherapy?
BioSpace
Mon, 05/13/24 - 10:50 am
cancer
oncology
cancer vaccines
R&D
How mRNA vaccines could be personalized cancer cures
Axios
Tue, 05/7/24 - 10:59 am
MRNA
vaccines
cancer
personalized medicine
oncology
IO Biotech
Merck
BioNTech
Delphia starts up with $67M to make a new type of cancer drug
BioPharma Dive
Thu, 05/2/24 - 11:28 am
Delphia Therapeutics
funding
cancer
activation lethality
Emergence of ADCs as the “hot, new technology”
Pharmaphorum
Thu, 04/25/24 - 11:39 am
antibody-drug conjugate
Immunogen
AbbVie
Seagen
Pfizer
cancer
M&A
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »